Sign in
4

Changes in Ownership

Aquestive Therapeutics, Inc. Filed Acc 0001140361-18-043653

SVP-Chief Financial Officer bought 10,000 shares at $9.80 ($98,000)

From the SEC's structured data for this filing

Trades in this filing

Maxwell John T. · SVP-Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-11-21 Purchase : show line 1 in the form +10,000 $9.80 $98,000 148,614 D
Open-market purchases · 10,000 sh · avg $9.80 · $98,000
Loading xslF345X03/form4.xml…